|
1
|
Strope SA and Montie JE: The causal role
of cigarette smoking in bladder cancer initiation and progression,
and the role of urologists in smoking cessation. J Urol. 180:31–37.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Huang RY and Chen GG: Cigarette smoking,
cyclooxygenase-2 pathway and cancer. Biochim Biophys Acta.
1815:158–169. 2011.PubMed/NCBI
|
|
3
|
Mitra AP, Castelao JE, Hawes D, et al:
Combination of molecular alternations and smoking intensity
predicts bladder cancer outcome: a report from the Los Angeles
Cancer Surveillance Program. Cancer. 119:756–765. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Wang YH, Yeh SD, Wu MM, et al: Comparing
the joint effect of arsenic exposure, cigarette smoking and risk
genotypes of vascular endothelial growth factor on upper urinary
tract urothelial carcinoma and bladder cancer. J Hazard Mater.
262:1139–1146. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Jensen OM, Knudsen JB, McLaughlin JK and
Sørensen BL: The Copenhagen case-control study of renal pelvis and
ureter cancer: role of smoking and occupational exposures. Int J
Cancer. 41:557–561. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ehdaie B, Furberg H, Zabor EC, et al:
Impact of smoking status at diagnosis on disease recurrence and
death in upper tract urothelial carcinoma. BJU Int. 111:589–595.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Hagiwara M, Kikuchi E, Tanaka N, et al:
Impact of smoking status on bladder tumor recurrence after radical
nephroureterectomy for upper tract urothelial carcinoma. J Urol.
189:2062–2068. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Rink M, Xylinas E, Margulis V, et al:
Impact of smoking on oncologic outcomes of upper tract urothelial
carcinoma after radical nephroureterectomy. Eur Urol. 63:1082–1090.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Crivelli JJ, Xylians E, Kluth LA, Rieken
M, Rink M and Shariat SF: Effect of smoking on outcomes of
urothelial carcinoma: a systematic review of the literature. Eur
Urol. 65:742–754. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Chen RJ, Chang LW, Lin P and Wang YJ:
Epigenetic effects and molecular mechanisms of tumorigenesis
induced by cigarette smoke: an overview. J Oncol. 2011:6549312011.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Miyata Y, Kanda S, Ohba K, et al:
Lymphangiogenesis and angiogenesis in bladder cancer: prognostic
implications and regulation by vascular endothelial growth
factors-A, -C, and -D. Clin Cancer Res. 12:800–806. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Bolenz C and Lotan Y: Translational
research in bladder cancer: from molecular pathogenesis to useful
tissue biomarkers. Cancer Biol Ther. 10:407–415. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Birrane G, Li H, Yang S, Tachado SD and
Seng S: Cigarette smoke induces nuclear translocation of heme
oxygenase 1 (HO-1) in prostate cancer cells: Nuclear HO-1 promotes
vascular endothelial growth factor secretion. Int J Oncol.
42:1919–1928. 2013.PubMed/NCBI
|
|
14
|
Miyata Y, Kanda S, Nomata K, Hayashida Y
and Kanetake H: Expression of metalloproteinase-2,
metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in
transitional cell carcinoma of the upper urinary tract: correlation
with tumor stage and survival. Urology. 63:602–608. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Bhuvarahamurthy V, Schroeder J, Denkert C,
et al: In situ gene expression of urokinase-type plasminogen
activator and its receptor in transitional cell carcinoma of the
human bladder. Oncol Rep. 12:909–913. 2004.PubMed/NCBI
|
|
16
|
AJCC, . Renal pelvis and ureter. In:
American Joint Committee on Cancer. AJCC Cancer Staging Manual.
6th. New York, NY: Springer; pp. 329–334. 2002
|
|
17
|
Mostofi FK, Sobin LH and Torloni H:
Histological typing of urinary bladder tumorsInternational
Histological Classification of Tumors, No. 10. Geneva: World Health
Organization; 1973
|
|
18
|
Miyata Y, Kanda S, Sakai H, Hakariya T and
Kanetake H: Relationship between changes in prostate cancer cell
proliferation, apoptotic index, and expression of apoptosis-related
proteins by neoadjuvant hormonal therapy and duration of such
treatment. Urology. 65:1238–1243. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Miyata Y, Sagara Y, Watanabe S, et al:
CD105 is a more appropriate marker for evaluating angiogenesis in
urothelial cancer of the upper urinary tract than CD31 or CD34.
Virchows Arch. 463:673–679. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Miyata Y, Kanda S, Ohba K, et al: Tumor
lymphangiogenesis in transitional cell carcinoma of the upper
urinary tract: association with clinicopathological features and
prognosis. J Urol. 176:348–353. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ohba K, Miyata Y, Kanda S, Koga S, Hayashi
T and Kanetake H: Expression of urokinase-type plasminogen
activator, urokinase-type plasminogen activator receptor and
plasminogen activator inhibitors in patients with renal cell
carcinoma: correlation with tumor associated macrophage and
prognosis. J Urol. 174:461–465. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Oku S, Higashi M, Imazono Y, et al:
Overexpression of cyclooxygenase-2 in high-grade human transitional
cell carcinoma of the upper urinary tract. BJU Int. 91:109–114.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ishida M, Mikami S, Kikuchi E, et al:
Activation of the aryl hydrocarbon receptor pathway enhances cancer
cell invasion by upregulating the MMP expression and is associated
with poor prognosis in upper urinary tract urothelial cancer.
Carcinogenesis. 31:287–295. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
von Hardenberg J, Martini T, Knauer A, et
al: Expression and predictive value of lymph-specific markers in
urothelial carcinoma of the bladder. Urol Oncol. 32:54.e9–17. 2014.
View Article : Google Scholar
|
|
25
|
Kamat AM, Sethi G and Aggarwal BB:
Curcumin potentiates the apoptotic effects of chemotherapeutic
agents and cytokines though down-regulation of nuclear factor-kappa
B and nuclear factor-kappa B-regulated gene products in
IFN-alpha-sensitive and IFN-alpha-resistant human bladder cancer
cells. Mol Cancer Ther. 6:1022–1030. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Badawi AF, Habib SL, Mohammed MA, Abadi AA
and Michael MS: Influence of cigarette smoking on prostaglandin
synthesis and cyclooxygenase-2 gene expression in human urinary
bladder cancer. Cancer Invest. 20:651–656. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Srivastava P, Mandhani A, Kapoor R and
Mittal RD: Role of MMP-3 and MMP-9 and their haplotypes in risk of
bladder cancer in North Indian cohort. Ann Surg Oncol.
17:3068–3075. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Shishodia S, Potdar P, Gairola CG and
Aggarwal BB: Curcumin (diferuloylmethane) down-regulates cigarette
smoke-induced NF-kappa B activation through inhibition of Ikappa
Balpha kinase in human lung epithelial cells: correlation with
suppression of COX-2, MMP-9 and cyclin D1. Carcinogenesis.
24:1269–1279. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Ye YN, Wu WK, Shin VY and Cho CH: A
mechanistic study of colon cancer growth promoted by cigarette
smoke extract. Eur J Pharmacol. 519:52–57. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Dellalibera-Joviliano R, Jacob-Ferreira
AL, Joviliano EE, Tanus-Santos JE and Evora PR: Imbalanced matrix
metalloproteinase-9 and tissue inhibitor of metalloproteinase-1
activities in patients with thromboangiitis obliterans. Vasc Med.
17:73–78. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Sivaraman SK, Zachariah G and Annamala P:
Effect of smoking on metalloproteinases (MMPs) activity in patients
with acute myocardial infarction (AMI). J Clin Diagn Res. 8:27–30.
2014.PubMed/NCBI
|
|
32
|
Ku JH, Byun SS, Jeong H, Kwak C, Kim HH
and Lee SE: Lymphovascular invasion as a prognostic factor in the
upper urinary tract urothelial carcinoma: a systematic review and
meta-analysis. Eur J Cancer. 49:2665–2680. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Chen X, Wan J, Liu J, et al: Increased
IL-17-producing cells correlate with poor survival and
lymphangiogenesis in NSCLC patients. Lung Cancer. 69:348–354. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Yoo YA, Kang MH, Lee HJ, et al: Sonic
hedgehog pathway promotes metastasis and lymphangiogenesis via
activation of Akt, EMT, and MMP-9 pathway in gastric cancer. Cancer
Res. 71:7061–7070. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Morita Y, Hata K, Nakanishi M, Nishisho T,
Yura Y and Yoneda T: Cyclooxygenase-2 promotes tumor
lymphangiogenesis and lymph node metastasis in oral squamous cell
carcinoma. Int J Oncol. 41:885–892. 2012.PubMed/NCBI
|
|
36
|
Lenz P, Pfeiffer R, Baris D, et al:
Cell-cycle control in urothelial carcinoma: large-scale tissue
array analysis of tumor tissue from Maine and Vermont. Cancer
Epidemiol Biomarkers Prev. 21:1555–1564. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Rahmani A, Alzohairy M, Khadri H, Mandal
AK and Rizvi MA: Expressional evaluation of vascular endothelial
growth factor (VEGF) protein in urinary bladder carcinoma patients
exposed to cigarette smoke. Int J Clin Exp Pathol. 5:195–202.
2012.PubMed/NCBI
|
|
38
|
Scheidt JH, Yurgel LS, Romanini J,
Cherubini K, de Figueiredo MA and Salum FG: Oral squamous cell
carcinoma from users and nonusers of tobacco and alcohol:
clinicopathologic features and immunoreactivity of VEGF, caspase-3,
and p 53. Appl Immunohistochem Mol Morphol. 21:148–153.
2013.PubMed/NCBI
|
|
39
|
Quentin T, Schlott T, Korabiowska M, et
al: Alteration of the vascular endothelial growth factor and
angiopoietins-1 and −2 pathways in transitional cell carcinomas of
the urinary bladder associated with tumor progression. Anticancer
Res. 24:2745–2756. 2004.PubMed/NCBI
|
|
40
|
Mondul AM, Rager HC, Kopp W, Virtamo J and
Albanes D: Supplementation with alpha-tocophenol or beta-carotene
reduces serum concentrations of vascular endothelial growth
factor-D, but not -A or -C, in male smokers. J Nutl. 141:2030–2034.
2011. View Article : Google Scholar
|
|
41
|
Lane D, Gray EA, Mathur RS and Mathur SP:
Up-regulation of vascular endothelial growth factor-C by nicotine
in cervical cancer cell lines. Am J Reprod Immunol. 53:153–158.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Inamine M, Nagai Y, Mitsuhashi A, et al:
Cigarette smoke stimulates VEGF-C expression in cervical
intraepithelial neoplasia (CIN) 1 and 2 lesions. Int J Clin Oncol.
17:498–504. 2012. View Article : Google Scholar : PubMed/NCBI
|
